Quince Therapeutics
QNCX
QNCX
50 hedge funds and large institutions have $3.44M invested in Quince Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
72% less capital invested
Capital invested by funds: $12.4M → $3.44M (-$8.95M)
87% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 23
Holders
50
Holding in Top 10
–
Calls
$228K
Puts
$72K
Top Buyers
| 1 | +$87.9K | |
| 2 | +$25K | |
| 3 | +$14K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.04K |
| 5 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$6.84K |
Top Sellers
| 1 | -$650K | |
| 2 | -$638K | |
| 3 | -$432K | |
| 4 |
BC
Burleson & Co
Petaluma,
California
|
-$188K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$169K |